Abortion is more entrenched in America than even I realized.
I thought, like most people, that the number of abortions in the United States would decrease after the Supreme Court overturned the infamous 1973 Roe v. Wade decision that forced abortion-on-demand on every state, regardless of their duly enacted laws. The overturn of Roe in the 2022 Dobbs v. Jackson Women’s Health Organization decision restored, after nearly 50 years, the right of states and elected officials to determine laws protecting life. Immediately following Dobbs, about 20 states enacted laws protecting the unborn, including about a dozen that enacted iron-clad protections.
Then President Joe Biden and Vice President Kamala Harris repeatedly argued that after Dobbs, women in states with pro-life protections would, in many cases, be unable to obtain abortions, either because it was illegal or practically inaccessible.
The reality is that far from decreasing, the abortion rate in the U.S. has climbed 21% between pre- and post-Dobbs America. Why? Because of policies put in place by the Biden administration when Roe was overturned that rapidly accelerated a decades-old push to expand abortion.
In the mid-90s, the French-made abortion pill made its way to the U.S. via the Population Council, but there was no company to manufacture and distribute the drug. So, a company was formed, backed by private funding, coordinated by the deep state, and operating with notable secrecy, incorporated in the Cayman Islands, with little public information beyond its name: Danco. And it’s only product? The abortion drug.
Danco is now trying to keep up with demand under the Biden-era policy that remains in place, which no longer requires in-person consultation or in-person dispensing of the drug. Chemical abortions now make up 63% of the roughly 1.2 million annual abortions in the U.S. In a move that baffled pro-lifers last year, the Trump FDA approved another company, Evita, to sell a generic version of the abortion drug at a reduced cost.
Danco and another abortion pill manufacturer, GenBioPro, filed with the Supreme Court last week to stop the 5th Circuit Court of Appeals from halting the Biden policies that offer no oversight of a drug that sends one in every 20 women to the emergency room. The companies claim the state of Louisiana, which is suing the FDA over the lax drug policy, has no legal right to sue. I am sure their position has nothing to do with the potential loss of profits if Louisiana prevails.
Louisiana has the right to call on the Supreme Court to stop the damage to its pro-life laws and to the health of its people. As recognized in Dobbs, Louisiana has passed laws to protect the unborn. Those laws are being eviscerated by federal policy. Taxpayers are covering the costs of any woman on Medicaid who ends up in the ER after taking the drug, while Danco, and its counterparts, GenBioPro and Evita, reap billions in profits at the public’s expense. Considering that one in 10 women report “severe adverse effects” from the pill, that’s no small amount of taxpayer dollars.
These abortion-by-mail manufacturers are not standing alone. The abortion industry and nearly every Democrat on Capitol Hill — 47 Senators and 212 House members — filed a brief in support of the abortion drug suppliers and the FDA. The National Organization for Women claimed that “Mifepristone is an essential lifeline for people who live in abortion-ban states.”
A lifeline? How Orwellian.
If the FDA refuses to voluntarily change its dangerous policy, the Supreme Court should give life to the words written in Dobbs and allow elected officials to protect their citizens — both born and unborn.
